AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$413M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$311M |
| 5 |
Microsoft
MSFT
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$260M |
| 2 |
Medtronic
MDT
|
+$239M |
| 3 |
T-Mobile US
TMUS
|
+$221M |
| 4 |
CELG
Celgene Corp
CELG
|
+$204M |
| 5 |
Nike
NKE
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 15.59% |
| 3 | Healthcare | 14.73% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Dorman Products
DORM
$3.98B
| $4.38M | ﹤0.01% |
50,230
+11,800
| +31% | +$1.03M |
|
1502
Acadia Pharmaceuticals
ACAD
$4.43B
| $4.38M | ﹤0.01% |
163,699
+9,700
| +6% | +$248K |
|
1503
Enovis
ENOV
$1.68B
| $4.37M | ﹤0.01% |
90,642
-2,539
| -3% | -$122K |
|
1504
H.B. Fuller
FUL
$2.97B
| $4.37M | ﹤0.01% |
94,256
+20,700
| +28% | +$954K |
|
1505
Enphase Energy
ENPH
$4.96B
| $4.37M | ﹤0.01% |
239,480
+153,880
| +180% | +$2.12M |
|
1506
Middleby
MIDD
$6.04B
| $4.36M | ﹤0.01% |
32,116
+1,683
| +6% | +$226K |
|
|
X
1507
DELISTED
US Steel
X
| $4.36M | ﹤0.01% |
284,556
-5,030
| -2% | -$77.5K |
|
1508
Coherent
COHR
$51.4B
| $4.35M | ﹤0.01% |
119,056
+24,268
| +26% | +$886K |
|
|
PMT
1509
PennyMac Mortgage Investment
PMT
$822M
| $4.35M | ﹤0.01% |
199,290
+65,372
| +49% | +$1.39M |
|
1510
Visteon
VC
$2.79B
| $4.34M | ﹤0.01% |
74,165
-8,473
| -10% | -$517K |
|
1511
8x8 Inc
EGHT
$269M
| $4.34M | ﹤0.01% |
179,946
+50,680
| +39% | +$1.18M |
|
|
CHNG
1512
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $4.31M | ﹤0.01% |
+295,392
| New | +$4.37M |
|
1513
Worthington Enterprises
WOR
$2.75B
| $4.31M | ﹤0.01% |
173,692
+1,947
| +1% | +$45.7K |
|
1514
Crocs
CROX
$6.14B
| $4.3M | ﹤0.01% |
217,807
+127,964
| +142% | +$2.96M |
|
|
GBT
1515
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.29M | ﹤0.01% |
81,500
+7,300
| +10% | +$420K |
|
1516
Universal Insurance Holdings
UVE
$1.22B
| $4.28M | ﹤0.01% |
153,560
+8,910
| +6% | +$261K |
|
1517
Albany International
AIN
$2.11B
| $4.28M | ﹤0.01% |
51,655
+12,400
| +32% | +$928K |
|
1518
Prestige Consumer Healthcare
PBH
$2.38B
| $4.28M | ﹤0.01% |
134,980
+3,210
| +2% | +$95.4K |
|
1519
First Financial Bancorp
FFBC
$3.55B
| $4.27M | ﹤0.01% |
176,338
+40,100
| +29% | +$964K |
|
|
WDR
1520
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.26M | ﹤0.01% |
255,730
+66,570
| +35% | +$1.16M |
|
|
CSFL
1521
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $4.26M | ﹤0.01% |
184,842
+58,075
| +46% | +$1.36M |
|
1522
J&J Snack Foods
JJSF
$1.43B
| $4.26M | ﹤0.01% |
26,444
+3,600
| +16% | +$575K |
|
1523
Usana Health Sciences
USNA
$408M
| $4.25M | ﹤0.01% |
53,541
+20,701
| +63% | +$1.64M |
|
1524
Atlantic Union Bankshares
AUB
$6.02B
| $4.25M | ﹤0.01% |
120,240
+19,400
| +19% | +$676K |
|
1525
Nelnet
NNI
$4.88B
| $4.25M | ﹤0.01% |
71,697
| – | – |
|
Similar funds
AllianceBernstein's Q2 2019 Portfolio in Review
As of Q2 2019, AllianceBernstein held 3,270 positions worth $161B, up 4.8% from $154B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q2 2019 filing shows 163 new, 1,818 increased, 1,043 reduced and 130 closed positions. Its largest new stake was Smartsheet Inc.: 1,910,302 shares worth $92.5M. The largest sale was Apple, an estimated $260M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2019 buy was Smartsheet Inc.: 1,910,302 shares worth $92.5M.
- AllianceBernstein added most to UnitedHealth in Q2 2019, an estimated $413M increase.
- AllianceBernstein's biggest Q2 2019 reduction was Apple, cutting an estimated $260M.
- AllianceBernstein fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2019, selling an estimated $177M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q2 2019.
- AllianceBernstein opened 163 new positions and closed 130 in Q2 2019.
- AllianceBernstein's portfolio value rose 4.8% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.